Resources|Articles|October 7, 2025

6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia

Key Takeaways

This infographic can help you review 6 highlights from the INTEGRATE Guidelines.

Read the cover story here.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia

ByLeighann Forbes, PhD

June 12th 2026

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

ByKim Do, PhD,Jessica Walters

June 3rd 2026

New Analysis of BXCL501 At-Home Administration Shows Reduction of Agitation in Bipolar and Schizophrenia

ByJessica Walters

May 29th 2026

Engaging With Patients With Acute Psychosis: A Conversation With Peter J. Weiden, MD

ByJohn J. Miller, MD,Peter J. Weiden, MD

May 26th 2026

schizophrenia_Generative AI_AdobeStock_762900677 Person with schizophrenia

World Schizophrenia Awareness Day: Why Curiosity and Lived Experience Matter in Serious Mental Illness Care

ByTracy Hicks, DNP, FNP/PMHNP-BC,Heidi Anne Duerr, MPH

May 24th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia

Key Takeaways

Related Content

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

New Analysis of BXCL501 At-Home Administration Shows Reduction of Agitation in Bipolar and Schizophrenia

Engaging With Patients With Acute Psychosis: A Conversation With Peter J. Weiden, MD

World Schizophrenia Awareness Day: Why Curiosity and Lived Experience Matter in Serious Mental Illness Care

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Monoamines: A Full House

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

Next Generation Pharmacotherapies for Mood and Anxiety Disorders: An ASCP Poster Presentation Recap